Teen Stress Is Expensive, Experts Say -- So How Can We Reduce It?
By Dennis Thompson HealthDay Reporter
THURSDAY, Jan. 16, 2025 -- Stressed-out teenagers appear to be dragging down the U.S. economy, a new study says.
Teenagers suffering from anxiety or depression are less likely to enter the workforce as young adults, and more likely to earn lower pay when they do, researchers reported in a study published today in the journal PLOS Medicine.
The economic impact is so great that $52 billion in U.S. budget savings could occur over 10 years if efforts are made to help even 10% of teens at risk for stress, researchers estimate.
“Our new research finds that, at the scale of the United States economy, improvements in adolescent mental health may bring many billions of dollars of federal budget benefits over ten years, potentially offsetting the costs of policy change that could cover critical services for young people,” lead researcher Nathaniel Counts, chief policy officer for The Kennedy Forum in Brigantine, NJ, said in a news release.
For the new study, researchers analyzed data on more than 3,300 participants in an ongoing Bureau of Labor Statistics study that is following children as they progress into adulthood.
The research team analyzed data gathered in 2000, when participants were 15 to 17, to check their mental health as teenagers. They looked specifically at questions that assessed anxiety and depression among the teens.
Researchers then looked at data gathered a decade later, in 2010, to see how the teens’ earlier mental health affected their job prospects as young adults.
Results show that 6% fewer people were holding down a job as a young adult if they suffered from clinically significant anxiety or depression as a teenager.
Young adults who were stressed as teens also earned nearly $5,700 less in annual wages, researchers found.
The researchers then estimated the potential impact on the U.S. budget if a hypothetical policy extended mental health preventive care to 10% of teens at risk of stress.
The added productivity from those teens who avoided stress amounted to $52 billion in additional federal revenue over 10 years.
The results support efforts like a 2023 law passed by Congress investing $60 million annually in U.S. mental health care, researchers said. That policy aims to expand access to mental health care at a rate of about 500 people for every $1 million spent.
“To reach 5 million people (roughly 25% of the adolescent population), the legislature would need to expand this program and invest at least $10 billion,” the research team wrote.
“Given the estimated savings of $52 billion over 10 years if the interventions can reach 10% of adolescents who would otherwise go on to develop depression, investments in adolescent mental health at scale will plausibly provide significant offsetting returns,” they concluded.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-01-17 06:00
Read more
- Higher Intake of Red Meat Linked to Increased Risk for Dementia
- Incentives Aid Smoking Cessation Across Populations
- Modest Decline Seen in Portal Messaging With Billing Implementation
- First U.S. Death From Bird Flu Reported in Louisiana
- Increased Surgeon Stress Linked to Reduced Surgical Complications
- Supreme Court to Decide on South Carolina's Bid to Cut Funding for Planned Parenthood
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions